NMS Capital Exits U.S. Urology Partners Investment
Deal News | Apr 09, 2025 | NMS Capital
NMS Capital, a private equity firm known for its focus on Healthcare Services and Business Services, has announced its divestment from U.S. Urology Partners. Established in 2018, U.S. Urology Partners became a major player in urological care under NMS's oversight, growing into an expansive network with over 180 providers across 50 clinical locations in states like Florida, Indiana, Massachusetts, New York, and Ohio. This spanned multiple specialties such as general urology, oncologic conditions related to the prostate and bladder, clinical research, and more. NMS’s investment strategy revolved around improving patient care accessibility and experience through its platform. The firm supported U.S. Urology Partners with strategic infrastructure investment, partnerships, and the introduction of specialist services, effectively positioning it as a market leader for urological services. Now, General Atlantic, a global investment firm, is set to continue U.S. Urology Partners' legacy. Corina Tracy, CEO of U.S. Urology Partners, acknowledged NMS's collaborative role in their success, appreciating the solid backing in scaling the platform and enhancing patient care. NMS's Luis Gonzalez reiterated their model of empowering physician autonomy while offering world-class care. Financial advisory roles were undertaken by Houlihan Lokey and Ernst & Young Capital Advisors, with McDermott Will & Emery offering legal counsel.
Sectors
- Healthcare Services
- Private Equity
- Business Services
Geography
- United States – U.S. Urology Partners operates across various states including Florida, Indiana, Massachusetts, New York, and Ohio, making the United States a central geography to the article.
Industry
- Healthcare Services – The article extensively covers U.S. Urology Partners, which operates within the healthcare domain, specifically providing urology services and related healthcare solutions across multiple locations.
- Private Equity – NMS Capital operates within the private equity industry, specializing in investments and strategic growth of companies like U.S. Urology Partners.
- Business Services – Both NMS and U.S. Urology Partners benefited from strategic business services to enhance operational efficiency and market reach.
Financials
- Assets in excess of $1.4 billion – NMS Capital's managed assets, demonstrating their capacity and expertise in investment.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| NMS Capital | Selling/Investment Exit | Company | A private equity firm focused on Healthcare and Business Services, which exited its investment from U.S. Urology Partners. |
| U.S. Urology Partners | Target Company | Company | A leading provider of urological services in the United States, backed previously by NMS Capital. |
| General Atlantic | Investor/Buyer | Company | A global growth investor that made a significant growth investment into U.S. Urology Partners. |
| Corina Tracy | Chief Executive Officer | Person | CEO of U.S. Urology Partners overseeing the operational and strategic activities of the company. |
| Luis Gonzalez | Senior Partner and Head of Healthcare | Person | Senior Partner at NMS Capital, involved in the strategic direction and execution of healthcare-related investments. |
| Houlihan Lokey | Lead Financial Advisor | Company | Provided financial advisory services to U.S. Urology Partners and NMS. |
| Ernst & Young Capital Advisors | Financial Advisor | Company | Provided additional financial advisory support to the transaction. |
| McDermott Will & Emery | Legal Counsel | Company | Provided legal advisory services to U.S. Urology Partners and NMS. |